Purchase Order HHSN272201501393P
Award Date 9/24/15
Potential Completion Date 3/29/17
Potential Value $365K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $99,612.73 firm fixed price purchase order contract to Fraunhofer USA, Inc. to produce ectodomain virus-like particles (VLPs) for the hemagglutinin (HA) molecules of influenza virus strains H1, H3, H5, and H7. The contract was not set aside and has a completion date of June 20, 2018. Fraunhofer USA, Inc. is a non-profit applied research and development...
- This federal contract award, identified as HHSN272201501390P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The $6,130.60 firm-fixed-price purchase order was awarded to Invivogen, a for-profit organization, on September 23, 2015 for the product "AMBIS 1755049 ODN1826, 5MG; PRODUCT ID TLRL-1826-5." The contract did not have a set-aside designation and is scheduled for completion on...
- This federal contract award, identified as HHSN272201400873P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $7,335.00 firm-fixed-price purchase order was awarded to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products, to provide 15 units of AMBIS 1695546 PLASMID PREP, 3MG, CAT # 3000, at a...
- This federal contract award, valued at $16,731,358.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to the Access To Advanced Health Institute (AAHI), a non-profit biotech research institute. The contract is for the continued development of vaccine candidates for biodefense, antimicrobial resistance, emerging infectious diseases, and respiratory pathogens. No set-aside designation was used. AAHI has subcontracted with several institutions, including Emory...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the NIAID Division of Microbiology and Infectious Diseases (DMID) Influenza Vaccine Project (H5N1) to develop influenza variant virus vaccines. The contract has a ceiling value of $19,476,349.00 and is a Delivery Order with a Cost Plus Fixed Fee...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract is a $70,108.14 delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for manufacturing and characterization services for vaccines and other biologics for infectious diseases. The...
- This federal contract award, valued at $1,469,410.09, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods and a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract is for NIAID...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Southern Research Institute, a corporate non-profit organization. The $452,600 contract is for the delivery of a "COMPREHENSIVE PANEL FOR VIRUSES" and is categorized as a Delivery Order under the NIAID's In Vitro Antimicrobial Assessments 2011-2018 contract vehicle. The contract has a firm fixed price and does not...
- This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
- This federal contract award, with ID HHSN272201600252P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $4,480.00, was awarded to Affymetrix, Inc., a for-profit manufacturer of goods, for the procurement of AMBIS 1771616 PROCARTAPLEX HUMAN CYTOKINE products. The contract was awarded on a firm-fixed price basis with a completion date of February 13, 2016. The...
This federal contract award, AMBIS #1748402, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Fraunhofer USA, Inc.'s Biotechnology Division Fraunhofer USA Center Mid-Atlantic, doing business as Fraunhofer Center For Molecular Biotechnology. The $364,793.00 firm fixed-price purchase order is for the development of influenza virus-like particles in a plant-based system. The contract does not have a set-aside designation and has an ultimate completion date of March 29, 2017. As NIAID is focused on research related to infectious diseases, this contract likely supports the agency's efforts to advance influenza vaccine development.
Generated 9/16/25, 10:03 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Production of Plant Derived Virus Like Particles | NOI1748402 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 8/24/15, 6:28 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Change Order | $0 | 9/21/16 | |
| Not listed | Not listed | $364.8k | 9/24/15 |